BioNTech’s Innovation Series R&D Day BioNTech leadership ... ii Kim HJ, et al. Arch Pharm Res. 2022;45(6):401-416.

Total revenue increased 11% to $133.5 million Net income of $16.1 million at a 12% margin; adjusted EBITDA increased to $50.6 million at a 38% margin NEW YORK ...

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...

The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...

A Winchester man who participated in a multi-state drug trafficking operation will be released from prison later this month ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Goldman Sachs has upgraded BioNTech SE (NASDAQ:BNTX), citing the company’s BNT327, an immuno-oncology asset in clinical ...

Both Moderna and Pfizer-BioNTech manufacture the COVID vaccine in lower doses ... A Kaiser Family Foundation survey from 2022 ...

Moderna chief executive officer Stéphane Bancel steps down as chief commercial officer, with president Stephen Hoge assuming ...

Florida Gov. Ron DeSantis is advocating for President-elect Donald Trump to tap Florida Surgeon General Joseph Ladapo for the role of HHS secretary.

New analyses highlight use of long-acting injectable Vocabria Rekambys (cabotegravir rilpivirine LA) in clinical trial and real-world populations, and the economic and public health impact ...

Moderna's Spikevax COVID vaccine brought in sales of $1.8 billion, up 3.5% over the previous year and handily beating analysts' average expectations of $1.38 billion. The company said it benefited ...